Related Experiment Video
Updated: Jul 13, 2026
09:47
Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)
Published on: September 13, 2018
[Cystic fibrosis: how to use pulmonary function tests].
F P Counil1, C Karila, M Le Bourgeois
1CHU Arnaud de Villeneuve, Montpellier, France. f-counil@chu-montpellier.fr
Revue Des Maladies Respiratoires
|July 17, 2007
Summary
Neonatal screening for cystic fibrosis (CF) enables early specialist care. This review examines pulmonary function test (PFT) guidelines for CF patients, focusing on test types, age, and clinical status, to optimize routine monitoring.
Area of Science:
- Pulmonology
- Pediatrics
- Medical Diagnostics
Context:
- Neonatal screening for cystic fibrosis (CF) ensures early access to specialized care.
- Pulmonary function tests (PFTs) are essential for routine monitoring of CF patients.
- Current guidelines for PFTs in CF require review regarding test selection, patient age, and clinical condition.
Purpose:
- To review current guidelines for pulmonary function tests (PFTs) in cystic fibrosis (CF) management.
- To assess the appropriate type of PFTs, optimal patient age, and clinical status for testing in CF.
- To provide a comprehensive overview of PFTs for the routine follow-up of CF patients.
Summary:
- Spirometry is widely accepted for routine CF monitoring.
- The clinical utility of various other PFTs in the routine follow-up of CF patients requires further establishment.
- More research is needed to evaluate the value of PFTs, especially in very young CF children.
Impact:
- Informs clinical practice regarding PFT selection and timing for CF patients.
- Highlights the need for evidence-based guidelines for PFTs in CF.
- Guides future research to establish the value of PFTs in pediatric CF care.
More Related Videos
Related Concept Videos
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:24Chest Physiotherapy
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.